|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy
|
Bruce V. Bigelow |
02/03/12 |
San Diego
|
|
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs
|
Arlene Weintraub |
01/19/12 |
New York
|
|
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes
|
Arlene Weintraub |
11/10/11 |
New York
|
|
Valeritas Raises $150M for Insulin Device
|
Arlene Weintraub |
09/13/11 |
New York
|
|
Metabolic Solutions Raises Another $6.8M
|
Sarah Schmid |
08/15/11 |
Detroit
|
|
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives
|
Luke Timmerman |
05/13/11 |
San Francisco
|
|
Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study
|
Ryan McBride |
03/03/11 |
Boston
|
|
SmartCells CEO Reflects on Strategy Leading to $500M Exit with Merck
|
Ryan McBride |
12/03/10 |
Boston
|
|
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
11/12/10 |
San Diego
|
|
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients
|
Luke Timmerman |
11/09/10 |
San Diego
|
|
Corengi Seeks to Bring Clinical Trial Information Into the World of Web 2.0
|
Luke Timmerman |
10/27/10 |
Seattle
|
|
Metabolic Solutions Development Grabs Venture Dollars For Diabetes Drugs, Gets New CEO
|
Ryan McBride |
10/21/10 |
Detroit
|
|
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News
|
Bruce V. Bigelow |
09/09/10 |
San Diego
|
|
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J
|
Ryan McBride |
09/09/10 |
Boston
|
|
Santarus to Launch Drug for Type 2 Diabetes
|
Bruce V. Bigelow |
09/08/10 |
San Diego
|
|
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online
|
Ryan McBride |
08/12/10 |
Boston
|
|
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline
|
Luke Timmerman |
07/14/10 |
Seattle
|
|
San Diego’s Neurocrine Biosciences Scores Second Big Deal in Two Days
|
Denise Gellene |
06/18/10 |
San Diego
|
|
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation
|
Luke Timmerman |
04/21/10 |
Boston
|
|
GI Dynamics Gets European Approval
|
Ryan McBride |
12/22/09 |
Boston
|
|
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes
|
Ryan McBride |
10/14/09 |
Boston
|
|
GI Dynamics Adds Device to Gut Liner to Increase Weight Loss
|
Ryan McBride |
04/29/09 |
Boston
|
|
Ex-Wyeth Exec Named Sirtris Pres.
|
Ryan McBride |
03/20/09 |
Boston
|
|
Elixir Reports Positive Results in Late-Stage Clinical Trial for Diabetes Drug
|
Ryan McBride |
11/19/08 |
Boston
|
|
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says
|
Luke Timmerman |
11/13/08 |
Boston
|
|
GI Dynamics Device Helps Obese Patients Shed 30 Pounds
|
Luke Timmerman |
09/26/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.